RT Journal Article
SR Electronic
T1 COVID-19 projections for reopening Connecticut
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.16.20126425
DO 10.1101/2020.06.16.20126425
A1 Crawford, Forrest W.
A1 Li, Zehang Richard
A1 Morozova, Olga
YR 2020
UL http://medrxiv.org/content/early/2020/06/19/2020.06.16.20126425.abstract
AB Key PointsClosure of schools and the statewide “Stay Safe, Stay Home” order have effectively reduced COVID-19 transmission in Connecticut, with model projections estimating incidence at about 1,300 new infections per day.If close interpersonal contact increases quickly in Connecticut following reopening on May 20, the state is at risk of a substantial increase of COVID-19 infections, hospitalizations, and deaths by late Summer 2020.Real-time metrics including case counts, hospitalizations, and deaths may fail to provide enough advance warning to avoid resurgence.Substantial uncertainty remains in our knowledge of cumulative COVID-19 incidence, the proportion of infected individuals who are asymptomatic, infectiousness of children, the effects of testing and contact tracing on isolation of infected individuals, and how contact patterns may change following reopening.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge NIH/NICHD grant 1DP2HD091799-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This analysis does not use individual-level patient data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used in this analysis are available from https://crawford-lab.github.io/covid19_ct/. https://crawford-lab.github.io/covid19_ct/